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Summary 
Accumulation of platelets in the microvasculature after acute myocardial ischemia may exacerbate 
tissue injury through the formation of microthrombi and by the release of vasoactive substances. To 
assess the role of platelets in myocardial ischemic injury and infarction, circulating platelets were 
reduced by 94 + 2 % (mean + S.E.M.) with sheep antiserum to canine platelets. Regional myocardial 
ischemia was produced by occlusion of the left circumflex coronary artery (LCCA) for 90 min followed 
by reperfusion for 5 hours. Infarct size did not differ significantly between antiplatelet serum and 
nonimmune serum groups: 36 + 8 vs. 43 + 4 % of the area at risk, determined by a post-mortem dual 
staining technique (p > 0.05). A second occlusion-reperfusion control group, sacrificed at 24 hours, did 
not differ from 5 hr reperfused groups with regard to infarct size. Coronary sinus thromboxane B2 
(TXB2) concentrations were not altered significantly by platelet depletion. Histopathologic examination 
confirmed the presence of necrosis in the infarcted myocardium and revealed substantial leukocytic 
infiltration in both groups. The results suggest that circulating platelets are not required for the full 
expression of myocardial ischemic injury resulting from temporary coronary artery occlusion followed 
by reperfusion. 
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Introduction 
There is little doubt that platelets accumulate within myocardial infarcts, as shown by 
experimental (25, 31) and autopsy (7) studies. The role of the blood platelet in the 
pathophysiology of developing myocardial infarcts is unclear. Platclets have been shown to 
form microemboli in ischemic myocardium (25, 19) and are known to release vasoactive 
substances, especially thromboxane A2 (TXA2) (13, 34). From these actions, a negative 
effect of platelets on myocardial infarction might be expected. However, Wilkerson e t  al. 
(36) have shown that platelet depletion did not affect ultimate myocardial infarct size in a 
canine model of complete coronary artery occlusion. In experimental studies, reperfusion 
has been shown to produce approximately 10-fold increase in platelet accumulation as 
compared to that found with permanent occlusion (21, 30). In the present study, the effect of 
antibody induced platelet depletion upon the expression of myocardial injury resulting from 
coronary artery occlusion]reperfusion was examined. Coronary sinus thromboxane B2 
(TXB2) concentrations also were measured as an index of the effects of platelet depletion 
and the subsequent development of myocardial injury due to regional TXA2 production. 
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Materials and methods 
Oeclusion-reperfusion model of myocardial infarction 
Ischemic myocardial injury was produced in dogs using techniques detailed in previous publications 
(18, 22). Male mongrel dogs (10 to 15 kg) were anesthetized with pentobarbital sodium (30 mg/kg 
intravenously), intubated, and ventilated with room air via a Harvard respirator. Catheters for drug 
infusion and arterial blood pressure recordings were implanted in the left jugular vein and left carotid 
artery respectively and were exteriorized at the back of the neck. A left thoracotomy was performed at 
the fifth intercostal space, the heart was suspended in a pericardial cradle, and the left circumflex 
coronary artera (LCCA) was isolated distal to its atrial branch and proximal to any major ventricular 
branches. An electromagnetic flowprobe and a micrometer-driven coronary occluder (16) were placed 
on the isolated segment. Coronary flow, ECG limb lead II and phasic arterial pressure were recorded 
continuously on a Grass Model 7 polygraph. 
Dogs were randomly assigned to platelet-depleted or non-depleted (control) groups. Thirty minutes 
before occlusion, 4 ml of either active antiplatelet serum or nonimmune serum was administered i.v. 
over a 5-minute period. Five minutes before occlusion, the occluder was adjusted to decrease the peak 
flow increment (reactive hyperemic response) after a 10-second complete occlusion by more than 70 % 
without changing resting flow. Regional myocardial ischemia then was produced by interrupting flow 
completely for 90 minutes. After this period of ischemia, flow was restored gradually over 30 minutes 
and the critical stenosis was retained for an additional 10 minutes. A supplemental dose of serum (4 ml) 
was given 1 hour after reperfusion. 
Two control groups were employed. In one, the thoracotomy was closed and on the next day, the 
ECG and arterial pressure were monitored for 1 hour with the dog resting quietly in a sling. The animal 
was then reanesthetized, the thoracotomy incision reopened, and the heart fibrillated electrically and 
removed rapidly for post-mortem quantification of infarct size. Only animals which survived occlusion 
by at least 20 hours were included. In the other control group, and also in the platelet depleted group, 
animals were maintained on the respirator for 5 hours of reperfusion. The hearts were fibrillated 
electrically and infarct size determined. In these preparations, left ventricular end diastolic pressure and 
left ventricular dP/dt were recorded continuously using a Millar micromanometer inserted through the 
apex of the heart. 
Post-mortem quantification of infarct size 
Myocardial infarct size was quantitated using a previously detailed in vitro dual perfusion technique 
(18). Cannulas were inserted into the LCCA immediately distal to the site of LCCA occlusion and into 
the aorta above the coronary ostia. The LCCA bed was perfused with 1.5 % triphenyltetrazolium 
hydrochloride (TTC) in 20-raM potassium phosphate buffer (pH 7.4, 38 ~ and the aorta perfused 
simultaneously in a retrograde manner with 0.5 % Evans blue. Both perfusion reservoirs were 
maintained at a constant pressure of 100 mmHg for 5 minutes. The hearts then were cut into six 1.0 cm 
thick sections, perpendicular to the apex-base axis. The area of the left ventricle at risk of infarction due 
to anatomical dependence on the LCCA for blood flow was identified by the lack of Evans blue stain 
while the regions of infarcted myocardium within the area at risk were demarcated by the lack of TTC 
staining. 
The transverse ventricular sections were traced carefully onto clear plastic overlays and analyzed by 
planimetry to determine the amount of left ventricle infarcted and at risk. Data presented in the Results 
section have been based on such planimetric estimates. However, in several hearts from each of the 
three groups, infarct and risk region masses also were determined by dissection. In these instances, 
ventricular sections were trimmed of right ventricular, valvular, and fatty tissue. The total left ventricle, 
area-at-risk, and infarct were then carefully dissected and weighed. Planimetric and gravimetric 
determinations of percent left ventricle infarcted and percent left ventricle at risk agreed closely and 
could be related as follows: planimetric estimate (% total left ventricle infarcted) = 1.02 • gravimetric 
estimate (g infarct) - 1.27; r = 0.92; n = 13. 
Production of  platelet antiserum 
Canine-platelet-rich plasma (PRP) was separated from whole blood by centrifugation for 15 minutes 
at 1300 rpm. Platelets were isolated from the PRP by gel filtration chromatography using sepharose 2B 
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equilibrated with a calcium-free 100 mM phosphate buffer (pH 7.0), according to a previously published 
procedure (27). Microscopic examination of the purified platelets revealed less than 1% contamination 
with other cells. Sheep were inoculated by intradermal injections of 5 x 109 dog platelets in incomplete 
Freund's adjuvant and after 25 days they were bled. The resulting sera were pooled and heat- 
inactivated. Nonimmune serum administered to the control group was prepared by bleeding non- 
challenged sheep. Circulating platelet counts were obtained from PRP prepared by collecting venous 
blood in 1 ml of 3.8 % sodium citrate to a total of 10 ml. This was centrifuged at 310 x g for 4 minutes 
and the platelet count per ml was obtained using a JT Baker MK/4Hc platelet counting system. 
Thromboxoane Be assay 
A silastic cannula 15 cm by 2 mm inner diameter was inserted ~a the jugular vein into the coronary 
sinus. One milliliter of freely flowing coronary venous blood was collected drop-wise after allowing the 
passage of 4 ml into a polypropylene tube containing I ml of an indomethacin (0.8 mg/ml) and EDTA (5 
mg/ml) solution at 0~ Samples were mixed gently and then centrifuged at 2,000 x g for 10 min at 4~ 
Plasma aliquots were stored at -70  ~ until assay (1 to 2 weeks). Before TXB2 determination, samples 
were deproteinized with acetonitrite, adjusted to pH 3.5 with formic acid and then extracted twice with 
ether. The resulting aqueous layer was washed twice with ethyl acetate, dried, and redissolved in 0.1% 
gel PBS for TXB 2 radioimmunoassay according to Fitzpatrick et al, (9) using rabbit-derived TXB2 
antibody (Upjohn). The sensitivity limit of the assay was 0.4 pg/ml. The percent cross reactivities of the 
assay were as follows: PGH2, 0.54; PGF2, 0.4; PGI2, 0.14; PGE2, 0.14; PGD2, 1.48; PGE1, 0.58. 
Extraction recoveries were determined for each sample and ranged from 61 to 83 %. 
Histological examination 
A ventricular section, approximately 5 mm thick, was taken at the level of the posterior papillary 
muscle and fixed in 10 % formalin. Tissue blocks were coded, paraffin embedded and cut 5 to 7 microns 
thick. Sections were stained with hematoxylin and eosin and examined by an observer (G.D.A.) who 
was unaware of the treatment code. The presence of necrosis, hemorrhage and leukocytic infiltration 
was examined. 
Statistics 
All data have been expressed as mean + S.E.M. Differences were considered significant when p < 
0.05. Student's t test was used to compare two groups. When more than two groups were being 
compared, one-way analysis of variance was employed followed by Duncan's Multiple Range Test. 
Multiple measurements within a group were compared using two-way analysis of variance. 
Results 
A total of  25 dogs was studied with seven,  24 hour  controls; six, 5 hour controls; and eight,  
5 hour  platelet  deplet ion exper iments  being comple ted  successfully. Two animals, one 
control and one platelet  depleted,  were  excluded because they failed to meet  the criteria for 
entry into the study. The  lack of electrocardiographic changes and epicardial cyanosis 
suggested that  these animals did not  undergo  severe ischemia. The  two remaining animals,  
one control  and one  platelet  depleted,  were  excluded because they failed to survive the 
exper imental  period.  Animal  weight  was similar in the three groups (table 1). 
Effects o f  sheep-derived antiserum on canine circulating platelet counts 
Effects of  antiplatelet  serum and control  non immune  serum have been examined previ- 
ously in this laboratory (33). Ant ipla te le t  serum produces greater  than 90 % deplet ion of 
circulating platelets for more  than 24 hours without  significant reduction in circulating 
neutrophils  over  an 8 hour  per iod while control  non immune  serum is without effect on 
circulating platelet  or  leukocyte  counts (33). In the present  study, circulating platelet  counts 
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Table 1. Hemodynamic parameters and body mass in control and platelet-depleted dogs before 
coronary occlusion. 
Controls n 
Body mass Heart rate Mean arterial Heart rate x Left circum- 
kg beats/min pressure systolic flex coronary 
mm Hg pressure units blood flow 
ml/min 
5 hours 6 13.0 + 1.0" 150 + 13 100 + 7 17.0 _+ 2.5 15 ___ 1 
24 hours 7 11.6 ___ 0.8 159 _+ 10 108 + 9 19.0 + 1.8 18 + 1 
Pla telet-depleted 
5hours  8 1 3 . 2 + 0 . 9  158+  8 1 1 4 + 6  19 .4+  1.4 18___2 
*~ + S.E.M. is given. No significant differences were observed. P > 0.05 by one-way analysis of 
variance followed by Duncan's Multiple Range Test. 
d e t e r m i n e d  on  b lood  samples  t a k e n  30 minu tes  af ter  admin i s t r a t ion  of an t i se rum,  were  
r educed  f rom 245 + 36 x 103 to 11 + 3 x 103 p l a t e l e t s /mm 3 PRP ,  a 94 + 2 % (~ + S . E . M . )  
dep le t ion .  N o n i m m u n e  se rum did no t  a l ter  p la te le t  counts .  
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Fig. 1. Hemodynamic parameters: heart rate (HR), mean arterial pressure (MAP), left ventricular end 
diastolic pressure (LVEDP), heart rate x systolic arterial pressure (Rx R), peak positive left ventricular 
dP/dt (+ dP/dt) and left circumflex coronary blood flow (CBF) are shown for the nonimmune serum and 
platelet depleted groups during the experimental period. Each point represents the mean value at that 
time. 
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Hemodynamic parameters 
Control hemodynamic parameters did not differ between nonimmune serum and platelet- 
depleted groups (table 1). In some animals, the injection of sheep serum, especially 
antiplatelet serum, produced a transient hypotension which had recovered before control 
measurements were made. Effects of left circumflex coronary artery occlusion and reperfu- 
sion upon hemodynamic parameters for the 5 hour reperfused groups are shown in figure 1. 
Similar responses to coronary artery occlusion were observed with no significant difference 
detected between the groups. In the first 5 minutes of occlusion, mean arterial pressure and 
peak positive left ventricular dP/dt fell while left ventricular end diastolic pressure rose. The 
gradual return of left circumflex coronary blood flow upon reperfusion, and the absence of a 
reactive hyperemia,  were possible with careful control of the micrometer-driven occluder. 
Ventricular ectopy was observed in all animals in the first 20 minutes of occlusion and after 
30 minutes of reperfusion. 
Myocardial infarct size 
Measurements of the percent of left ventricle anatomically dependent on the occluded left 
circumflex coronary artery and of myocardial infarct size are shown in figure 2 for 
nonimmune serum and platelet antiserum groups. There was no difference in the amount of 
myocardium at risk between the three groups. Myocardial infarct, determined by the dual 
staining technique with TTC, was 43 + 4 and 42 _+ 3 percent of the area-at-risk in nonim- 
mune serum groups reperfused for 5 hours and 24 hours, respectively. The platelet-depleted 
group developed myocardial infarcts of 36 +_- 8 percent. This small reduction, approximately 
15 %, was not statistically significant. In light of recent criticisms of the TTC technique, as 
used in a 6 hour complete occlusion protocol (8), it is important that 5 hour reperfused and 
24 hour reperfused infarcts did not differ with regard to ultimate infarct size. 
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Fig. 2. Lack of effect of platelet depletion upon myocardial infarct size is shown. The three groups: 
nonimmune, control serum (CS,n = 6), platelet depletion (PD, N = 8) and nonimmune control serum 
with 24 hour reperfusion (24, n = 7) are indicated by dotted, lined and open bars, respectively. The 
infarcted zone is normalized as a percent of the area-at-risk (IZ/AR %, panel A) or percent of the total 
left ventricle (IZ/TLV %, panel B). The amount of jeopardized myocardium is normalized as area at 
risk as a percent of the total left ventricle (AR/TLV %, panel C). No significant differences were 
observed between the three groups. 
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Fig. 3. Thromboxanc B2 concentrations (TXB2, pg/ml) in coronary sinus blood plasma are shown for the 
nonimmune serum and the platelet-depleted groups. Platelet depletion did not effect coronary sinus 
TXB~ as judged from between group or within group comparisons. TXBz levels during left circumflex 
coronary artery occlusion were not different from prc-serum concentrations in either group. Both 
groups showed significant increases in coronary sinus TXB: concentrations in the late reperfusion phase 
as compared to the plasma TXB2 concentration 60 minutes after occlusion. B - baseline; A serum; R 
= reperfusion. Time in minutes is shown on the abscissa. 
Thromboxat~e Be in coronary sinus plasma 
TXB2, the stable degradation product of TXA2, was examined in coronary sinus plasma 
samples. Before serum administration no difference in plasma TXB2 (pg/ml) was observed 
between groups: platelet depletion (270 + 66, n = 7), nonimmune serum (236 Y 40, n = 5). 
The effect of depleting circulating platelets by 94 % and of subsequent coronary occlusion on 
this parameter are shown in figure 3. While coronary sinus TXB~ levels did not change 
compared to baseline, there was a tendency in both groups for coronary sinus TXB2 to 
decrease in late occlusion and rebound during reperfusion (fig. 3). In the depleted group, 
TXB2 levels measured after 60 minutes of occlusion (164 _+ 38) were significantly less than 
concentrations at 90 minutes after reperfusion (370 + 112 p~ml). In the nonimmune serum 
group, tXB+ levels measured after 60 minutes of occlusion (148 _+ 14) were significantly less 
than levels at 60 minutes after reperfusion (428 + 168 pg/ml). However, the physiological 
significance of these differences is hard to evaluate in light of the variability in this 
parameter. 
Histopathologic examination 
Histopathologic examination of myocardium sampled at different sites within the midven- 
tricular tissue section showed no striking differences between the two 5 hour reperfused 
groups. Tissue samples from myocardium stained blue or brick red were confirmed as bcing 
viable. In contrast, nonstaining myocardium within the area-at-risk had undergone extensive 
necrosis characterized by hyalinization and loss of myofibrillar detail, patchy foci of 
contraction bands alternating with flocculent cytoplasm and nuclear changes. In both 
nonimmune serum and platelet-depleted animals, infarcted myocardium showed prominent 
leukocytic infiltration. A section from a thrombocytopenic animal demonstrating infarcted 
myocardium and leukocytic infiltration is shown in figure 4. 
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Fig. 4. A section of infarcted myocardium from a platelet depleted dog is shown, Structural disorganiza- 
tion, cytoplasmic changes such as contraction bands, flocculent cytoplasm, and loss of nuclei can bc 
observed. A prominent leukocytic infiltrate is present. 
Discussion 
This study failed to demonstrate a protective effect of platclet depiction in myocardial 
ischemic injury due to occlusion/rcperfusion of the LCCA. It is unlikely that a possible 
protective action of platelet depletion was obscured by other factors. Body weight and scx 
were controlled (22), and heart rate, mean arterial pressure and LCCA coronary blood flow 
did not differ between groups. Due to control of the site of LCCA occlusion, the am,,mnt of 
left ventricle jeopardized is very consistant (18, 22, 30), and did not differ betwcen groups in 
this study. Regional myocardial blood flow was not studied, so variability between groups in 
this factor cannot be ruled out. Most of the previous investigations using this model of 
myocardial infarction utilized a 24-hour reperfusion period (18, 22, 31)). However, Romson 
et al. (29) and the present study have found that 6- and 5-hour reperfusion pcriods in control 
276 Basic Research in Cardiology, Vol. 80, No. 3 (1985) 
animals produce infarcts of greater than 40 % of the area-at-risk, equivalent to those 
observed at 24 hours. The nonimmune sheep serum group developed infarcts similar in size 
to those of saline treated animals (15) and nonimmune rabbit serum also had no effect on 
infarct size (29). Finally, agents other than the antisera, excepting supplemental pentobarbi- 
tal, were not given to the dogs to avoid possible interference with the expression of ischemia 
as has been suggested with lidocaine (4). A lack of protection of jeopardized myocardium by 
severe thrombocytopenia has also been observed by Wilkerson et al. (36) in a coronary 
artery embolization model allowing 24 hours of complete occlusion. 
In complete occlusion, platelet delivery to the developing infarct may be limited by low 
ischemic blood flow. Significant entry does occur, but it has been observed primarily on the 
borders of the infarct (25, 31). The relatively small [1- to 4-fold (25, 31)] platelet accumula- 
tion may minimize effects of thrombocytopenia. Since reperfusion allows exaggerated [10- 
to 30-fold (21, 30)] entry of platelets into the jeopardized region, the present occlusion/ 
reperfusion model of experimental infarction might be more likely to detect a platelet- 
dependent component of tissue injury. Instead, no significant effect of platelet depletion was 
observed, which is consistent with results obtained with complete occlusion (36). 
These results do not imply that stimulated platelets cannot produce ischemia. Injections of 
ADP into the coronary vasculature of pigs causes thrombosis in the microvasculature and 
ensuing myocardial infarction that is not observed in pigs rendered thrombocytopenic by p32 
(19). In Langendorff-perfused rabbit hearts, addition of human platelets to the perfusate 
followed by activation with thrombin causes myocardial ischemia due to microthrombosis 
(1). Partial constriction of coronary arteries using circumferential occluders produces 
significant cyclical thrombosis with brief periods of ischemia (10). Electrical stimulation of 
the coronary intima produces thrombi characterized by a white tail composed predominantly 
of platelets entrapped in a fibrin meshwork and a head containing a mixture of platelets, red 
cells, and leukocytes (28). In this coronary artery injury model, platelet depletion prevents 
thrombosis and subsequent myocardial infarction (33). 
Several reports have suggested that TXA2 contributes to myocardial ischemic injury and 
arrhythmias (1, 6, 13, 17, 34). The lack of an effect of platelet depletion may be due to the 
inability of such depletion to depress circulating TXB~ levels. McDonald et al. (23) have 
reported a similar phenomenon where pulmonary hypertension, leukostasis and TXBz 
production were not affected by platelet depletion (23). Perhaps other sources of TXA2 
must be considered, such as circulating leukocytes (11). The perfused isolated heart has also 
been reported to produce thromboxane in a cardiac hypersensitivity model (2). Our "basal" 
canine coronary sinus TXB2 concentrations were close to those reported by others (5, 6) and 
changed only slightly upon LCCA occlusion and in the early phase of reperfusion. The lack 
of a significant elevation in coronary sinus TXA2 after 15 minutes of coronary occlusion is in 
agreement with Coker et al. (6). However, these investigators did detect a significant 
increase when TXB2 was measured in samples obtained from the coronary vein draining the 
ischemic region (6). Our studies may not reflect the actual course of events with respect to 
TXB2 contributed from the reperfused region, because the venous drainage from this area is 
diluted by venous blood from normally perfused myocardium. Furthermore, the increase in 
the TXB2 plasma concentrations in the late phase of reperfusion might have resulted in part 
from polymorphonuclear leukocytes that would accumulate in the injured reperfused 
myocardial region. 
While ventricular arrhythmias were not quantitated in this study, significant ventricular 
ectopy was observed in both groups during early occlusion and upon reperfusion. Low TXB2 
concentrations during late occlusion rising during reperfusion tend to support the hypothesis 
that TXA2 contributes to arrhythmogenesis (6, 17, 24). An antiarrhythmic effect of aspirin 
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has been reported (6, 24) and attributed to inhibition of TXA2 synthesis (6). In addition, the 
thromboxane synthetase inhibitor, RO-22-4679, has been shown to reduce the incidence of 
ventricular fibrillation in conscious dogs (17). However, inhibition of TXA2 synthesis with 
imidazole did not affect the frequency of ectopic beats during reperfusion (5). In clinical 
studies~ increased TXA2 has been reported during myocardial ischemia (14). 
The present study was part of an investigation of inflammation in myocardial ischemia and 
reperfusion. The onset of irreversible tissue injury in regional ischemia is faster than that in 
global ischemia (32). This may be attributable to entry of blood components delivered by the 
residual blood flow via functional collateral vessels. Although both platelets and leukocytes 
enter the reperfused ischemic myocardium, platelet entry was not affected by ibuprofen 
treatment which reduced infarct size by 40 % (30). Leukocyte entry, on the other hand, was 
reduced significantly by ibuprofen compared to controls (30), Anti-platelet serum (throm- 
bocytopenia) did not reduce myocardial infarct size in either complete occlusion (36) or 
reperfusion models. Antisera to canine polymorphonuclear leukocytes significantly reduces 
the amount of irreversible tissue injury in this model (15, 29). In addition, a protective effect 
of neutrophil depletion has been reported recently in a complete coronary artery occlusion 
model (20). Entry of leukocytes into myocardial infarcts is an active chemotactic process 
stimulated by products of tissue injury such as complement fragments and products of 
arachidonic acid metabolism (12, 26). In the present study, prominent leukocytic infiltration 
was observed in infarcts from both thrombocytopenic dogs and controls. These studies 
would suggest that the leukocyte, rather than the platelet, is responsible for the inflamma- 
tory component of cell death in myocardial infarction. 
Since the present studies were acute, wound healing was not examined. Platelets are 
among the first cells to adhere to injured surfaces in the microvasculature (35). The potential 
importance of collagen stimulated aggregation in thrombosis has been emphasized (12). 
However, recent studies suggest that antiplatelet drugs delay endothelial repair (3). A 
possible beneficial effect of platelets would not be detectable in the time frame of this study. 
In conclusion, depletion of circulating platelets by 94 % did not significantly affect the 
ultimate fate of myocardium jeopardized by LCCA occlusion plus reperfusion. Secondly, 
platelet depletion did not reduce coronary sinus TXB2 concentrations suggesting that TXA2 
may be derived from sources other than the platelets. The importance of platelet-mediated 
thrombosis in the initiation of an ischemic event was not addressed in this study but is 
recognized as being of utmost importance in precipitating an acute myocardial infarction. 
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